Non-Alcoholic Fatty Liver Disease — A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
Citation(s)
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) and Elevated Alanine Aminotransferase (ALT)